Colonial Trust’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Colonial Trust's AMED Position: Q3 2023 in Review
Colonial Trust sold out of Amedisys (AMED) in Q3 2023, closing a stake of 122 shares — an estimated $11.2K sold.
Colonial Trust first reported a position in AMED in Q4 2022 and held it in 3 quarters. The position peaked at $11.2K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Colonial Trust reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Colonial Trust sold 122 Amedisys shares in Q3 2023, an estimated $11.2K.
- Colonial Trust first reported a position in Amedisys in Q4 2022 and held it in 3 quarters.
- Colonial Trust's Amedisys position peaked at $11.2K in Q2 2023.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Colonial Trust's 13F filing for Q3 2023, filed 13 Nov 2023.